Skip to main content

Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.

Publication ,  Conference
Waldman, WJ; Knight, DA; Lurain, NS; Miller, DM; Sedmak, DD; Williams, JW; Chong, AS
Published in: Transplantation
September 27, 1999

BACKGROUND: Despite progress in antiviral chemotherapy, cytomegalovirus (CMV) remains a major cause of morbidity and mortality among pharmacologically immunosuppressed organ transplant recipients, frequently engaging the clinician in a struggle to balance graft preservation with control of CMV disease. Leflunomide, an inhibitor of protein kinase activity and pyrimidine synthesis, is an experimental immunosuppressive agent effective against acute and chronic allograft rejection in animal models. Because a number of CMV proteins are known to be phosphorylated, we tested the hypothesis that this agent might exert inhibitory activity against CMV. METHODS AND RESULTS: Plaque assays demonstrated dramatic dose-dependent attenuation of production of multiple clinical CMV isolates in leflunomide-treated human fibroblasts and endothelial cells, common targets for CMV infection in vivo. As shown by Northern blot analysis and immunohistochemical staining, leflunomide neither interferes with transcription of immediate early or late viral genes, nor with expression of corresponding proteins. CMV-specific DNA dot blots and biochemical enzyme assays indicated that, in contrast to currently approved anti-CMV drugs, leflunomide exerts no inhibitory effect on the accumulation of viral DNA in infected cells, or on viral DNA polymerase activity. Rather, as visualized by transmission electron microscopy, this agent appears to act at a late stage in virion assembly by preventing tegument acquisition by viral nucleocapsids. Finally we have demonstrated equivalent inhibitory activity of leflunomide against multi-drug-resistant CMV isolates. CONCLUSIONS: These findings imply that leflunomide, an effective immunosuppressive agent, shows potential to concurrently attenuate a major complication of immunosuppression, CMV disease, by a novel mechanism of antiviral activity.

Duke Scholars

Published In

Transplantation

DOI

ISSN

0041-1337

Publication Date

September 27, 1999

Volume

68

Issue

6

Start / End Page

814 / 825

Location

United States

Related Subject Headings

  • Virus Replication
  • Viral Proteins
  • Umbilical Veins
  • Transcription, Genetic
  • Time Factors
  • Surgery
  • Male
  • Leflunomide
  • Isoxazoles
  • Immunosuppressive Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Waldman, W. J., Knight, D. A., Lurain, N. S., Miller, D. M., Sedmak, D. D., Williams, J. W., & Chong, A. S. (1999). Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. In Transplantation (Vol. 68, pp. 814–825). United States. https://doi.org/10.1097/00007890-199909270-00014
Waldman, W. J., D. A. Knight, N. S. Lurain, D. M. Miller, D. D. Sedmak, J. W. Williams, and A. S. Chong. “Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.” In Transplantation, 68:814–25, 1999. https://doi.org/10.1097/00007890-199909270-00014.
Waldman WJ, Knight DA, Lurain NS, Miller DM, Sedmak DD, Williams JW, et al. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. In: Transplantation. 1999. p. 814–25.
Waldman, W. J., et al. “Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.Transplantation, vol. 68, no. 6, 1999, pp. 814–25. Pubmed, doi:10.1097/00007890-199909270-00014.
Waldman WJ, Knight DA, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation. 1999. p. 814–825.

Published In

Transplantation

DOI

ISSN

0041-1337

Publication Date

September 27, 1999

Volume

68

Issue

6

Start / End Page

814 / 825

Location

United States

Related Subject Headings

  • Virus Replication
  • Viral Proteins
  • Umbilical Veins
  • Transcription, Genetic
  • Time Factors
  • Surgery
  • Male
  • Leflunomide
  • Isoxazoles
  • Immunosuppressive Agents